Skip to main content

Browse Clinical Trials (783 trials open to new patients)

Cancer (758 trials open to new patients)

Acute Lymphoblastic Leukemia (22) Acute Myeloid Leukemia (37) Adenocarcinoma (1) Anal Cancer (5) Anal Intraepithelial Neoplasia (1) Angiosarcoma (1) Astrocytoma (27) Atypical Teratoid Rhabdoid Tumor (2) Basal Cell Carcinoma (4) Biliary Tract Cancer (6) Bladder Cancer (31) Bone Cancer (4) Brain and Central Nervous System Tumor (2) Brain Metastases (4) Breast Cancer (86) Cancer, General (38) Cancer Screening (1) Carcinoid Tumor (2) Carcinoma, Intraductal, Noninfiltrating (1) Cervical Adenosquamous Carcinoma (4) Cervical Cancer (15) Cholangiocarcinoma (11) Chordoma (2) Choriocarcinoma (2) CNS Tumor (2) Colorectal Cancer (49) Colorectal Tumor (1) Congenital Mesoblastic Nephroma (3) Cutaneous Malignancy (1) Endometrial Cancer (16) Ependymoma (10) Epithelioid Sarcoma (1) Esophageal Cancer (7) Estrogen Receptor Negative (5) Estrogen Receptor Positive (1) Ewing Sarcoma (13) Fallopian Tube Cancer (7) Fibrolamellar Carcinoma (1) Fibrosarcoma (1) Gallbladder Cancer (1) Ganglioneuroblastoma (3) Gastroesophageal Junction Adenocarcinoma (3) Gastrointestinal Cancer Metastatic (1) Germ Cell Tumor (11) Gestational Trophoblastic Tumor (1) Glioblastoma (22) Glioma (52) Gliosarcoma (2) Head and Neck Cancer (36) Head and Neck Squamous Cell Carcinoma (27) Head and Neck Tumor (4) Hematological Malignancy (2) Hepatic Cancer (1) Hepatocellular Cancer (2) HER2 (23) Hodgkin's Lymphoma (7) Hypopharynx Cancer (1) Immunotherapy (20) INI1-negative Tumors (1) Kidney Cancer (33) Langerhans Cell Histiocytosis (11) Laryngeal Cancer (3) Leiomyosarcoma (1) Leukemia (76) Lip and Oral Cavity Cancer (2) Liposarcoma (1) Liver Cancer (29) Lung Cancer (106) Lung Tumor (2) Lymphoma (77) Malignant Neoplasm (20) Malignant Peripheral Nerve Sheath Tumor (2) Malignant Solid Neoplasm (23) Mantle Cell Lymphoma (7) Medulloblastoma (12) Melanoma (45) Meningioma (2) Merkel Cell Carcinoma (1) Mesothelioma (8) Metastatic Cancer (4) Metastatic Malignant Solid Neoplasm (8) Metastatic Neoplasm (1) Mucinous Adenocarcinoma (1) Multiple Myeloma (19) Myelodysplasia (1) Nasopharyngeal Cancer (4) Nasopharynx Cancer (1) Neoplasm (5) Neoplasm Metastasis (2) Neoplasms by Site (1) Neuroblastoma (24) Neuroendocrine Tumor (7) Non Hodgkin Lymphoma (37) Non-Small Cell Lung Cancer (68) Oligodendroglioma (2) Oral Cavity Cancer (1) Oropharyngeal Cancer (1) Oropharynx Cancer (2) Osteosarcoma (14) Ovarian Cancer (26) Ovarian Clear Cell Adenocarcinoma (3) Ovarian Embryonal Carcinoma (1) Ovarian Mucinous Adenocarcinoma (2) Ovarian Serous Adenocarcinoma (2) Ovarian Tumor (1) Pancreatic Cancer (28) PEComa (1) Penile Cancer (1) Peripheral Primitive Neuroectodermal Tumor (6) Peritoneal Cancer (6) Pheochromocytoma (1) Primary Peritoneal Serous Adenocarcinoma (2) Progesterone Receptor Negative (5) Progesterone Receptor Positive (1) Prostate Cancer (75) Refractory Central Nervous System Neoplasm (12) Refractory Malignant Solid Neoplasm (18) Refractory Plasma Cell Myeloma (3) Refractory Tumor (1) Renal Cell Carcinoma (25) Renal Pelvis Cancer (2) Rhabdoid Tumor (12) Rhabdomyosarcoma (13) Salivary Gland Cancer (2) Sarcoma (33) Selected Tumors With Rhabdoid Features (1) Seminoma (2) Skin Cancer/Melanoma (47) Soft Tissue Sarcoma (16) Solid Cancers (1) Solid Neoplasm (7) Solid Tumor (104) Squamous Intraepithelial Lesion (1) Stomach Cancer (20) Synovial Sarcoma (2) T Cell Lymphoma (6) Teratoma (3) Testicular Cancer (1) Testicular Tumor (1) Thyroid Cancer (7) Thyroid Gland Carcinoma (5) Thyroid Gland Medullary Carcinoma (1) Unresectable Solid Neoplasm (4) Ureter Cancer (2) Urethral Cancer (3) Urinary Bladder Tumor (3) Uterine Cancer (6) Vaginal Cancer (2) Waldenstrom Macroglobulinemia (1) Wilms Tumor (11)

Immune System (2 trials open to new patients)

Infectious Diseases (15 trials open to new patients)

Injuries (1 trials open to new patients)

Mental Health (1 trials open to new patients)

Metabolic Problems (2 trials open to new patients)

Organ and Tissue Transplant (4 trials open to new patients)

Reproductive Health (3 trials open to new patients)

Surgical Studies (1 trials open to new patients)

Other (264 trials open to new patients)

Abnormal DNA Repair (1) Acinar Cell Carcinoma (1) Activating Mutations (1) Activating RAS Mutation (1) Acute Promyelocytic Leukemia (1) Adenoid Cystic Carcinoma (1) Adrenal Cortex Carcinoma (2) Adrenal Gland Pheochromocytoma (1) Adrenocortical Carcinoma (1) Adrenocortical Carcinoma (Part G) (1) Aggressive Fibromatosis (1) Aggressive NHL (a NHL) (1) Aggressive Systemic Mastocytosis (1) ALK Fusion Protein Expression (1) ALK Gene Mutation (1) ALK Gene Rearrangement (3) ALK Gene Translocation (2) ALK Positive (2) ALK-positive Advanced NSCLC (1) Anal Basaloid Carcinoma (1) Anal Canal Cloacogenic Carcinoma (1) Anal Canal Neuroendocrine Carcinoma (1) Anal Canal Undifferentiated Carcinoma (1) Antibiotic Allergy (1) Antibiotics (1) Apocrine Neoplasm (1) Appendix Mucinous Adenocarcinoma (1) ARAF Gene Mutation (1) ATM Gene Mutation (1) Autoimmune Disease (1) B Cells--Tumors (1) Barrett's Esophagus (1) Basal Cell Nevus Syndrome (1) BCR-ABL1 Fusion Protein Expression (1) BCR/ABL1 Fusion Protein Negative (1) Bladder Small Cell Neuroendocrine Carcinoma (1) Blood Clot (1) BRAF Gene Mutation (2) BRAF NP_004324.2:p.V600X (2) BRAF V600 Wild Type (1) BRAF V600E Mutation Present (1) BRAF V600K Mutation Present (1) Breast Screening (1) Breast Secretory Carcinoma (1) BRIP1 Gene Mutation (1) Bronchial Neoplasms (1) c-MET Gene Amplification (1) Cancer, Metastatic (1) Cancer Prevention (1) Carcinoma Breast (1) Carcinoma, Bronchogenic (1) Carcinoma, Ductal, Breast (1) Cardiotoxicity (1) Cardiovascular Complication (1) Castration Levels of Testosterone (1) CD19 Positive (1) CD20 Negative (1) CD20 Positive (1) CD22 Positive (2) Central Nervous System Embryonal Tumor (1) Cervical Clear Cell Adenocarcinoma (1) CHEK2 Gene Mutation (1) Chemoembolization, Therapeutic (1) Chest Wall Disease (1) Chronic Lymphocytic Leukemia (12) CNS Malignancies (1) Colon Cancer (10) Complete Response (1) Cutaneous T-Cell Lymphoma (2) Cytopenia (1) Decision Support Systems, Clinical (1) Deep Vein Thrombosis (1) Deleterious ATM Gene Mutation (1) Deleterious RAD51C Gene Mutation (1) Deleterious RAD51D Gene Mutation (1) Desmoid-Type Fibromatosis (2) Differentiated Thyroid Gland Carcinoma (1) Digestive System Neuroendocrine Neoplasm (1) DNA Repair Disorder (1) Dyspnea (1) EGFR Activating Mutation (2) EGFR Exon 19 Deletion Mutation (4) EGFR Exon 20 Insertion Mutation (2) EGFR Gene Amplification (1) EGFR Gene Mutation (1) EGFR NP_005219.2:p.G719X (2) EGFR NP_005219.2:p.L858R (4) EGFR NP_005219.2:p.L861Q (2) EGFR NP_005219.2:p.T790M (2) EGFR T790M Mutation Negative (1) Elevated Alpha-Fetoprotein (1) Ependymal Tumor (1) Epstein Barr Virus (2) ERBB2 Gene Amplification (1) Esophageal Carcinoma (2) Esophageal Neuroendocrine Carcinoma (1) Esophageal Undifferentiated Carcinoma (1) Esophagogastric Junction (1) Esophagogastric Junction Neoplasm (1) Extensive Stage Lung Small Cell Carcinoma (1) Extragonadal Embryonal Carcinoma (1) Eyelid Diseases (1) EZH2 Gain of Function (1) EZH2 Gene Mutation (1) Fatigue (2) FGFR1 Gene Mutation (1) FGFR2 Amplification (1) FGFR2 Gene Mutation (2) FGFR3 Gene Mutation (1) FGFR4 Gene Mutation (1) Fibromyxoid Tumor (1) FIGO Stage III-IV (1) Gallbladder Carcinoma (1) Gastric Neuroendocrine Carcinoma (1) Gastric Undifferentiated Carcinoma (1) Gastro-esophageal Junction (GEJ) Cancer (1) Gastrointestinal Cancer (1) Gastrointestinal Neoplasms (1) Gastrointestinal Stromal Tumor (6) Genitourinary Cancer (1) Giant Cell Carcinoma (1) Giant Cell Tumors (1) GNA11 Gene Mutation (2) GNAQ Gene Mutation (2) Hematologic Cancer (1) Hematologic Malignancies (2) Hematologic Neoplasms (1) Hematopoietic and Lymphoid Cell Neoplasm (1) Hematopoietic Cell Transplantation (3) Hemispheric (1) Hepatic Carcinoma (1) Hepatoblastoma (11) Hepatocellular Carcinoma (25) Histiocytic and Dendritic Cell Neoplasm (1) Histiocytic Disorders (1) Histiocytosis (6) HLA-A*0201 Positive Cells Present (2) HNSCC (1) HRAS Gene Mutation (2) HRAS Mutant Tumor (1) Human Papillomavirus (5) Hypercalcemia (1) Hypopharyngeal Carcinoma (2) IDH1 Gene Mutation (3) IDH2 Gene Mutation (4) Infantile Fibrosarcoma (1) Infection (1) Intermediate Grade Lung Neuroendocrine Neoplasm (1) Intestinal Neoplasms (1) Intestinal Neuroendocrine Carcinoma (1) Juvenile Xanthogranuloma (1) Kaposi's Sarcoma (6) KRAS Gene Mutation (3) KRAS wt Allele (1) Lip SCC (1) Locally Advanced Chordoma (1) Locally Advanced Malignant Solid Neoplasm (3) Locally Advanced Solid Neoplasm (1) Loss of BRG1 Protein Expression (1) Loss of INI 1 Protein Expression (1) Low Grade Lung Neuroendocrine Neoplasm (1) Lung Large Cell Carcinoma (1) Lung Neuroendocrine Neoplasm (1) Lung Non-Small Cell Cancer (7) Lung Non-Small Cell Carcinoma (7) Lung Non-Squamous Non-Small Cell Carcinoma (3) Lung Sarcomatoid Carcinoma (1) Lung Small Cell Carcinoma (1) Lymphadenopathy (1) Lymphedema (1) Major Salivary Gland Carcinoma (1) Malignancies Multiple (1) Malignancies (1) Malignant Central Nervous System Neoplasm (2) Malignant Neoplastic Disease (1) Malignant Neuroendocrine Carcinoma (Diagnosis) (1) Malignant Odontogenic Neoplasm (1) Malignant Ovarian Brenner Tumor (1) Malignant Rhabdoid Tumor (1) Malignant Testicular Sex Cord-Stromal Tumor (1) Malignant Uterine Neoplasm (1) MAP2K1 Gene Mutation (1) MAPK1 Gene Mutation (1) Matched Targeted Therapy (1) Mesothelin Positive (1) Metastasis (1) Metastatic Chordoma (1) Metastatic Lung Non-Small Cell Carcinoma (1) Metastatic Thyroid Gland Carcinoma (1) Microsatellite Instability (1) Microsatellite Stable (1) Minimal Residual Disease (1) Mismatch Repair Deficiency (1) Mismatch Repair Protein Proficient (1) MITF Positive (1) Mixed Mesodermal (Mullerian) Tumor (1) Mixed Oligoastrocytoma (2) MMR-deficient Tumors (1) Monosomy 7 (1) Mucinous Cystadenocarcinoma (1) Mycosis Fungoides (1) Mycosis Fungoides (MF) (1) Myelofibrosis (2) Myeloma (1) Myeloproliferative Neoplasms (4) Narcotic Use (1) Nasal Cavity Adenocarcinoma (1) Nasal Cavity Carcinoma (1) Nasopharyngeal Papillary Adenocarcinoma (1) Nasopharyngeal Undifferentiated Carcinoma (1) Nausea and Vomiting (1) NBN Gene Mutation (1) Neoplasm Malignant (1) Neoplasm of Bone (1) Neoplasm of Lung (1) Neoplasms, Colorectal (1) Neoplasms, Nerve Tissue (1) Neoplasms Pancreatic (1) Neuroendocrine Carcinoma (1) Neuroendocrine Neoplasm (2) Newly Diagnosed (1) NF1 Gene Mutation (3) NMYC Gene Amplification (1) Nodule Solitary Pulmonary (1) Non-Small-Cell Lung (1) Non-urothelial Bladder (1) Non-urothelial Upper Tract (1) NRAS Gene Mutation (2) NRAS wt Allele (1) NSCLC, Recurrent (1) NSCLC Stage IIIB (1) NSCLC, Stage IIIC (1) NSCLC, Stage IV (1) NTRK1 Fusion Positive (1) NTRK2 Fusion Positive (1) NTRK3 Fusion Positive (1) NY-ESO-1 Positive (1) NY-ESO-1 Positive Tumor Cells Present (1) Oligometastasis (1) Oral Cancer (1) Oral Cavity Carcinoma (1) Oral Cavity Verrucous Carcinoma (1) Oropharyngeal (p16-Negative) Carcinoma (2) Oropharyngeal Undifferentiated Carcinoma (1) Oropharynx Cancer, Metastatic (1) Oropharynx Cancer, Recurrent (1) Oropharynx Cancer, Stage III (1) Ovarian Seromucinous Carcinoma (2) Ovarian Undifferentiated Carcinoma (1) p16 Positive Neoplastic Cells Present (1) Paget's Disease (1) PALB2 Gene Mutation (1) Pancreatic Acinar Cell Carcinoma (1) Pancreatic Diseases (1) Pancreatic Ductal Adenocarcinoma (2) Pancreatic Neuroendocrine Carcinoma (1) Paranasal Sinus Adenocarcinoma (1) Paranasal Sinus Carcinoma (1) Parathyroid Gland Carcinoma (1) Partial Response (1) Pathologic Stage I Merkel Cell Carcinoma (1) Pathologic Stage II Merkel Cell Carcinoma (1) Pathologic Stage IIA Merkel Cell Carcinoma (1) Pathologic Stage IIB Merkel Cell Carcinoma (1) Pathologic Stage III Merkel Cell Carcinoma (1) Pathologic Stage IIIA Merkel Cell Carcinoma (1) Pathologic Stage IIIB Merkel Cell Carcinoma (1) PD-L1 Positive (1) Pediatric Cancer (1) Pediatric Central Nervous System Tumor (1) Pharmacokinetics of Fluorouracil Bolus (5-FU) (1) Pharmacokinetics of Oxaliplatin (1) Pharmacokinetics of Zolbetuximab (1) Philadelphia Chromosome Positive (2) Pituitary Gland Carcinoma (1) Plasma Cell Myeloma (4) Plasmacytoma (1) Plexiform Neurofibroma (1) Poorly Differentiated Thyroid Gland Carcinoma (2) Positive Lymph Node (1) Postmenopausal (2) Primary Peritoneal (1) Progressive Disease (2) Prostate Neuroendocrine Neoplasm (1) Prostate Small Cell Carcinoma (1) PSA Level Greater Than 0.03 (1) PSA Level Greater Than or Equal to Two (1) PSA Progression (3) Pseudomyxoma Peritonei (1) PTPN11 Gene Mutation (1) Pulmonary Disease (1) RAD51 Gene Mutation (1) Radiation Toxicity (1) Rare Disorder (1) RB1 Positive (1) Rectal Cancer (7) Refractory Cancer (1) Refractory Central Nervous System Tumor (1) Refractory Germ-cell (1) Refractory Hepatoblastoma (4) Refractory Langerhans Cell Histiocytosis (8) Refractory Neoplasm (1) Refractory Neurofibromatosis Type 1 (1) Refractory Osteosarcoma (8) Relapsed Central Nervous System Tumor (1) Renal Medullary Carcinoma (1) Renal Pelvis Neoplasms (2) Resected Mass (1) Resistant Cancer (1) Respiratory Tract Neoplasms (1) Richter's Syndrome (2) ROS1 Fusion Positive (1) ROS1 Gene Mutation (1) ROS1 Gene Translocation (1) Salivary Cancer (1) Salivary Gland Neoplasms (1) Sdh (1) Seminal Vesicle Adenocarcinoma (1) Serous Cystadenocarcinoma (1) Sinonasal Carcinoma (1) Sleep Disorders (1) Small Intestinal Adenocarcinoma (1) SMARCA4 Gene Inactivation (1) SMARCB1 Gene Inactivation (1) SMARCB1 Gene Mutation (1) Spinal Column Tumor (1) Spindle Cell Neoplasm (1) Splenomegaly (1) Squamous Cell Carcinoma (41) Squamous Intraepithelial Neoplasia (1) Stomach Neoplasms (1) Stromal Neoplasm (1) Surgical Incision (1) Surgical Site Infection (1) Surgical Wound Infection (1) Surgical Wound, Recent (1) TFE3 Gene Translocation (1) TFEB Gene Translocation (1) Thoracic Neoplasms (1) Thyroid Gland Follicular Carcinoma (2) Thyroid Gland Oncocytic Follicular Carcinoma (1) Thyroid Gland Papillary Carcinoma (2) TP53 wt Allele (1) Tracheal Carcinoma (1) Transitional Cell Carcinoma (33) Treatment-Related Cancer (1) Trisomy 21 Mosaicism (1) TSC1 Gene Mutation (2) TSC2 Gene Mutation (2) Tumors (1) Tumor Metastasis (1) Tumor Neck (1) Tumor Recurrence (1) Tumor Types With FGFR2 Gene Fusions (1) Unresectable Chordoma (1) Unresectable Esophageal Carcinoma (1) Unresectable Gallbladder Carcinoma (1) Unresectable Malignant Solid Neoplasm (1) Ureter Adenocarcinoma (1) Ureter Small Cell Carcinoma (1) Ureteral Neoplasms (2) Urethral Adenocarcinoma (1) Urethral Neoplasms (2) Urologic Neoplasms (2) Uterine Neoplasms (1) Vaginal Adenocarcinoma (2) Vaginal Adenosquamous Carcinoma (1) Vulvar Carcinoma (1)